Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22805320)

  • 1. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
    Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
    Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
    Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
    J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
    BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
    Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
    Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
    Jonsson L; Gaber A; Ulmert D; Uhlén M; Bjartell A; Jirström K
    Diagn Pathol; 2011 Sep; 6():91. PubMed ID: 21955582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
    Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
    Ye F; Jin P; Cai X; Cai P; Cai H
    Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
    Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
    PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
    Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
    Biomark Res; 2017; 5():10. PubMed ID: 28293425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.
    Wennersten C; Andersson G; Boman K; Nodin B; Gaber A; Jirström K
    Diagn Pathol; 2014 Oct; 9():189. PubMed ID: 25278252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
    Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K
    BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome.
    Bengtsson E; Nerjovaj P; Wangefjord S; Nodin B; Eberhard J; Uhlén M; Borgquist S; Jirström K
    Diagn Pathol; 2014 Apr; 9():78. PubMed ID: 24708688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study.
    Fridberg M; Jonsson L; Bergman J; Nodin B; Jirström K
    Biol Sex Differ; 2012 Jul; 3(1):16. PubMed ID: 22748166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of Mcm3 and Mcm4 expression in cervical squamous cell carcinomas.
    Gan N; Du Y; Zhang W; Zhou J
    Eur J Gynaecol Oncol; 2010; 31(3):291-4. PubMed ID: 21077471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.
    Zhao Y; Wang Y; Zhu F; Zhang J; Ma X; Zhang D
    Clin Exp Med; 2020 May; 20(2):249-259. PubMed ID: 31980982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.
    Ehlén A; Brennan DJ; Nodin B; O'Connor DP; Eberhard J; Alvarado-Kristensson M; Jeffrey IB; Manjer J; Brändstedt J; Uhlén M; Pontén F; Jirström K
    J Transl Med; 2010 Aug; 8():78. PubMed ID: 20727170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
    Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
    Biomark Res; 2014; 2():11. PubMed ID: 24963396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.